BIOSIGHT
BioSight is a biopharmaceutical private company founded in 2000 and re launched in mid 2009, revolutionizing the research and development of innovative cancer targeted pro-drugs. BioSight has developed technology S2DOT TM and a pipeline of targeted pro-drugs, that can target and release chemotherapy drugs inside cancer cells, while significantly minimizing the systemic toxicity associated with conventional chemotherapy treatments.
BIOSIGHT
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Carmiel, HaZafon, Israel
Country:
Israel
Website Url:
http://www.biosight-pharma.com
Total Employee:
1+
Status:
Active
Contact:
972 4 958 1519
Email Addresses:
[email protected]
Total Funding:
59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
KBP Biosciences
A multinational clinical stage biotechnology company.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Founder
Investors List
Migdal Insurance and Financial Holdings
Migdal Insurance and Financial Holdings investment in Series C - BioSight
Israel Biotech Fund
Israel Biotech Fund investment in Series C - BioSight
Arkin Bio Ventures
Arkin Bio Ventures investment in Series C - BioSight
Primera Capital
Primera Capital investment in Series C - BioSight
Phoenix Insurance Company
Phoenix Insurance Company investment in Series C - BioSight
Biotel
Biotel investment in Series C - BioSight
Arkin Bio Ventures
Arkin Bio Ventures investment in Series C - BioSight
Israel Biotech Fund
Israel Biotech Fund investment in Series C - BioSight
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series C - BioSight
Arkin Holdings
Arkin Holdings investment in Venture Round - BioSight
Official Site Inspections
http://www.biosight-pharma.com Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
